Cơ Chế Tác Dụng :
NB001 is the first antimicrobial product in phase II clinical trials for the topical treatment of herpes labialis.
NB001 is developed by NanoBio with an additional pharmaceutical treatments utilizing the NanoStat antimicrobial technology for fungal, viral and bacterial infections of the skin and mucous membranes. In addition to Herpes labialis, clinical trials has begun with NanoTxt, which is a topical treatment for nail fungus (onychomycosis). NanoBio's product has the potential to be the first topical treatment for nail fungus with efficacy similar to systemic medications.
Chỉ Định :
Investigated for use/treatment in herpes labialis infections (cold sores).